UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
Embecta (Nasdaq: EMBC), a global diabetes care company specializing in insulin delivery, has announced it will host a conference call on November 26, 2024, at 8:00 a.m. ET. The call will cover the company's fiscal fourth quarter and full year 2024 financial results, along with an operational update and preliminary fiscal year 2025 financial guidance. Investors can access the event via live webcast or teleconference, with a replay available from 11:00 a.m. ET on the same day through the company's investor relations website for one year.
Embecta (Nasdaq: EMBC), un'azienda globale nel settore della cura del diabete specializzata nella somministrazione dell'insulina, ha annunciato che ospiterà una conference call il 26 novembre 2024 alle ore 8:00 ET. Durante la chiamata verranno trattati i risultati finanziari del quarto trimestre fiscale e dell'intero anno 2024, insieme a un aggiornamento operativo e una guida finanziaria preliminare per l'anno fiscale 2025. Gli investitori potranno accedere all'evento tramite webcast dal vivo o teleconferenza, con una replica disponibile dalle 11:00 ET dello stesso giorno sul sito web delle relazioni con gli investitori della società per un anno.
Embecta (Nasdaq: EMBC), una empresa global de atención a la diabetes especializada en la entrega de insulina, ha anunciado que llevará a cabo una llamada de conferencia el 26 de noviembre de 2024 a las 8:00 a.m. ET. La llamada cubrirá los resultados financieros del cuarto trimestre fiscal y del año completo 2024, junto con una actualización operativa y una guía financiera preliminar para el año fiscal 2025. Los inversores pueden acceder al evento a través de una transmisión web en vivo o teleconferencia, y una repetición estará disponible a partir de las 11:00 a.m. ET el mismo día en el sitio web de relaciones con inversores de la compañía durante un año.
Embecta (Nasdaq: EMBC), 인슐린 전달에 특화된 글로벌 당뇨병 관리 회사는 2024년 11월 26일 오전 8시 ET에 컨퍼런스 콜을 개최한다고 발표했습니다. 이 콜에서는 2024 회계 연도 4분기 및 전체 연도 재무 결과뿐만 아니라 운영 업데이트와 2025 회계 연도에 대한 초기 재무 안내가 포함될 것입니다. 투자자들은 생방송 웹캐스트 또는 전화 회의를 통해 이벤트에 접근할 수 있으며, 같은 날 오전 11시 ET부터 회사의 투자자 관계 웹사이트를 통해 1년 동안 재생 가능할 것입니다.
Embecta (Nasdaq: EMBC), une entreprise mondiale spécialisée dans le soin du diabète et la livraison d'insuline, a annoncé qu'elle organisera une conférence téléphonique le 26 novembre 2024 à 8h00 ET. La conférence portera sur les résultats financiers du quatrième trimestre et de l'année complète 2024, ainsi qu'une mise à jour opérationnelle et des prévisions financières préliminaires pour l'année fiscale 2025. Les investisseurs peuvent accéder à l'événement via un webinaire en direct ou par téléconférence, avec une rediffusion disponible à partir de 11h00 ET le même jour sur le site Web des relations investisseurs de l'entreprise pendant un an.
Embecta (Nasdaq: EMBC), ein globales Unternehmen für Diabetesversorgung, das sich auf die Insulinabgabe spezialisiert hat, hat bekannt gegeben, dass es am 26. November 2024 um 8:00 Uhr ET eine Telefonkonferenz abhalten wird. In der Konferenz werden die finanziellen Ergebnisse des vierten Quartals und des Gesamtjahres 2024 sowie ein operatives Update und eine vorläufige Finanzprognose für das Geschäftsjahr 2025 behandelt. Investoren können die Veranstaltung über einen Live-Webcast oder eine Telefonkonferenz verfolgen, mit einer Wiederholung, die am selben Tag ab 11:00 Uhr ET über die Website der Investor Relations des Unternehmens für ein Jahr verfügbar sein wird.
- None.
- None.
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 26, 2024.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 26, 2024, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
When will Embecta (EMBC) report its Q4 and FY 2024 earnings?
How can investors access Embecta's (EMBC) Q4 2024 earnings call?
Will Embecta (EMBC) provide FY 2025 guidance during its Q4 2024 earnings call?
